Basics Sarepta Therapeutics, Inc. Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases. IPO Date: July 12, 2012 Sector: Healthcare Industry: Biotech Market Cap: $1.79B Activated in VL: True Average Daily Range Avg Daily Range: $1.56 | 2.43% Avg Daily Range (30 D): $0.83 | 3.88% Avg Daily Range (90 D): $1.56 | 3.56% Institutional Daily Volume Avg Daily Volume: 1.64M Avg Daily Volume (30 D): 10M Avg Daily Volume (90 D): 5.68M Trade Size Avg Trade Size (Sh.): 106 Avg Trade Size (Sh.) (30 D): 115 Avg Trade Size (Sh.) (90 D): 95 Institutional Trades Total Inst.Trades: 13,360 Avg Inst. Trade: $4.07M Avg Inst. Trade (30 D): $3.04M Avg Inst. Trade (90 D): $3.51M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $8.71M Avg Closing Trade (30 D): $12.67M Avg Closing Trade (90 D): $14.83M Avg Closing Volume: 103K     News Jul 21, 2025 @ 2:15 PM SRPT Investors Have Opportunity to Join Sarepta Th... Source: Prnewswire Jul 20, 2025 @ 3:44 PM Bragar Eagel & Squire, P.C. Reminds Investors That... Source: Bragar Eagel & Squire, P.C. Jul 20, 2025 @ 2:46 PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LL... Source: Faruqi & Faruqi, Llp Jul 18, 2025 @ 7:15 PM SRPT BREAKING NEWS: Sarepta Therapeutics, Inc. (NA... Source: Bleichmar Fonti & Auld Llp Jul 18, 2025 @ 5:18 PM Stocks Slip As Netflix Fails To Impress, Bitcoin E... Source: Piero Cingari Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.51 $-4.6 $1.67 Diluted EPS $-2.63 $-4.6 $1.56 Revenue $ 2.23B $ 744.86M $ 658.41M Gross Profit $ $ $ Net Income / Loss $ -248.39M $ -447.51M $ 159.05M Operating Income / Loss $ -117.21M $ -300.39M $ 161.68M Cost of Revenue $ $ $ Net Cash Flow $ -186.42M $ -862.14M $ 905.16M PE Ratio     Splits Jul 12, 2012:   1:6